Table 3.
Summary of shoulder PJI studies that include revision arthroplasty.
| Study | Patients (TSAs) | Management (cases per treatment) | Three most commonly isolated organisms in order of incidence | Mean follow-up in months (range) | Eradication rate (%) |
|---|---|---|---|---|---|
| Coste et al.13 | 42 (49) | Multiple - Antibiotics (5) - Resection (10) - Debridement (8) - Single-stage (3) - Two-stage (10) - Spacer/other (3) | Staphylococcus epidermidis Propionibacterium acnes Staphylococcus aureus | 32 (12–96) | 71 |
| Ince et al.35 | 16 (16) | Single-stage | CNS Propionibacterium sp. Streptococcus | 70 (13–160) | 100 |
| Strickland et al.38 | 17 (19) | Two-stage | Propionibacterium sp. CNS Staphylococcus aureus | 35 (24–80) | 63 |
| Beekman et al.6 | 11 (11) | Single-stage | Propionibacterium acnes CNS Escherichia coli | 24 (12–36) | 90.9 |
| Romanò et al.39 | 44 (44) | Multiple - Two-stage (17) - Spacer (15) - Resection (6) - Debridement (5)a | CNS Staphylococcus aureus Propionibacterium acnes | 41 (21–98) | 95.5 |
| Klatte et al.40 | 35 (35)b | Single-stage | Staphylococcus epidermidis Propionibacterium acnes Staphylococcus capitis | 56 (13–162) | 94 |
| Jacquot et al.37 | 32 (32) | Multiple - Two-stage (14) - Debridement (13) - Resection (6) - Single-stage (5) | CNS Propionibacterium acnes Otherc | 37 (12–137) | 81 |
| This study | 28 (28) | Two-stage | Propionibacterium acnes MSSA CNS/Staphylococcus epidermidis | 38.3 (9–88) | 80d |
CNS: coagulase negative staphylococcus; MSSA: methicillin sensitive Staphylococcus aureus.
aThree debridement cases received exchange of mobile parts.
bIncludes nine cases previously reported by Ince et al. (see main text).
cOther: remaining cultures had equal incidence.
d80% indicates the eradication rate for the 25 cases managed with second-stage revision with TSA reimplantation.